Insider Stock Trading History of Van Naarden Jacob


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Van Naarden Jacob since year 2005. The trader's CIK number is 1661254. At the time of this reporting, Van Naarden Jacob is the Chief Business Officer of Loxo Oncology, Inc. . (stock ticker symbol LOXO). See this page for all insider trading activities at Loxo Oncology, Inc. .


Stock purchases, sales, and option exercises reported by insider Van Naarden Jacob since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-02-13 LOXO Loxo Oncology, Inc. Sale 1,541 97.46 150,187
2018-02-12 LOXO Loxo Oncology, Inc. Option Ex 1,541 3.65 5,621
2018-02-13 LOXO Loxo Oncology, Inc. Option Ex 1,541 3.65 5,621
2018-02-12 LOXO Loxo Oncology, Inc. Sale 1,541 93.51 144,098
2018-01-17 LOXO Loxo Oncology, Inc. Option Ex 1,541 3.65 5,621
2018-01-16 LOXO Loxo Oncology, Inc. Option Ex 1,541 3.65 5,621
2018-01-17 LOXO Loxo Oncology, Inc. Sale 1,541 88.34 136,127
2018-01-16 LOXO Loxo Oncology, Inc. Sale 1,541 88.50 136,380
2017-12-15 LOXO Loxo Oncology, Inc. Sale 1,541 79.93 123,175
2017-12-14 LOXO Loxo Oncology, Inc. Option Ex 1,541 3.65 5,621
2017-12-15 LOXO Loxo Oncology, Inc. Option Ex 1,541 3.65 5,621
2017-12-14 LOXO Loxo Oncology, Inc. Sale 1,541 83.33 128,414
2017-11-27 LOXO Loxo Oncology, Inc. Option Ex 1,541 3.65 5,621
2017-11-28 LOXO Loxo Oncology, Inc. Option Ex 1,541 3.65 5,621
2017-11-27 LOXO Loxo Oncology, Inc. Sale 1,541 75.27 115,989
2017-11-28 LOXO Loxo Oncology, Inc. Sale 1,541 74.27 114,456
2017-10-30 LOXO Loxo Oncology, Inc. Option Ex 1,541 3.65 5,621
2017-10-31 LOXO Loxo Oncology, Inc. Option Ex 1,541 3.65 5,621
2017-10-30 LOXO Loxo Oncology, Inc. Sale 1,541 87.81 135,310
2017-10-31 LOXO Loxo Oncology, Inc. Sale 1,541 86.66 133,535
2017-09-19 LOXO Loxo Oncology, Inc. Sale 1,541 88.93 137,045
2017-09-18 LOXO Loxo Oncology, Inc. Sale 1,541 89.11 137,318
2017-09-19 LOXO Loxo Oncology, Inc. Option Ex 1,541 3.65 5,621
2017-09-18 LOXO Loxo Oncology, Inc. Option Ex 1,541 3.65 5,621
2017-08-15 LOXO Loxo Oncology, Inc. Option Ex 1,541 3.65 5,621
2017-08-14 LOXO Loxo Oncology, Inc. Sale 1,541 73.81 113,741
2017-08-15 LOXO Loxo Oncology, Inc. Sale 1,541 73.42 113,134
2017-08-14 LOXO Loxo Oncology, Inc. Option Ex 1,541 3.65 5,621

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Van Naarden Jacob (Chief Business Officer of Loxo Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.